NO20071038L - Epotilonkombinasjoner. - Google Patents

Epotilonkombinasjoner.

Info

Publication number
NO20071038L
NO20071038L NO20071038A NO20071038A NO20071038L NO 20071038 L NO20071038 L NO 20071038L NO 20071038 A NO20071038 A NO 20071038A NO 20071038 A NO20071038 A NO 20071038A NO 20071038 L NO20071038 L NO 20071038L
Authority
NO
Norway
Prior art keywords
epotilonkombinasjoner
epothilone
concomitant
progression
treat
Prior art date
Application number
NO20071038A
Other languages
English (en)
Inventor
Sara L Zaknoen
Paul M J Mcsheehy
Richard Paul Beckner
Anandhi Ranganathan Johri
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20071038L publication Critical patent/NO20071038L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen vedrører to kombinasjoner av (a) et epotilon med (b) to eller flere andre antineoplastiske midler for samtidig, separat eller sekvensiell anvendelse, særlig for å forsinke progresjonen av, eller å behandle, en proliferativ sykdom.
NO20071038A 2004-07-26 2007-02-23 Epotilonkombinasjoner. NO20071038L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59122504P 2004-07-26 2004-07-26
PCT/EP2005/008076 WO2006010585A1 (en) 2004-07-26 2005-07-25 Epothilone combinations

Publications (1)

Publication Number Publication Date
NO20071038L true NO20071038L (no) 2007-04-26

Family

ID=35058801

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071038A NO20071038L (no) 2004-07-26 2007-02-23 Epotilonkombinasjoner.

Country Status (17)

Country Link
US (1) US20090041715A1 (no)
EP (1) EP1773334A1 (no)
JP (1) JP2008507573A (no)
KR (1) KR20070037498A (no)
CN (1) CN1988904A (no)
AU (1) AU2005266484A1 (no)
BR (1) BRPI0513825A (no)
CA (1) CA2573949A1 (no)
IL (1) IL180604A0 (no)
MA (1) MA28812B1 (no)
MX (1) MX2007000971A (no)
NO (1) NO20071038L (no)
RU (1) RU2007106931A (no)
TN (1) TNSN07025A1 (no)
TW (1) TW200616626A (no)
WO (1) WO2006010585A1 (no)
ZA (1) ZA200700201B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2009114A1 (en) * 2007-06-29 2008-12-31 Bayer Schering Pharma Aktiengesellschaft Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones
US20100267682A1 (en) * 2007-11-09 2010-10-21 Novartis Ag Corticosteroids to treat epothilone or epothilone derivative induced diarrhea
US20110300150A1 (en) 2010-05-18 2011-12-08 Scott Eliasof Compositions and methods for treatment of autoimmune and other disease
US8974811B2 (en) 2013-03-14 2015-03-10 Hikma Pharmaceuticals Stabilized pharmaceutical formulations comprising antineoplastic compounds
CN107041886A (zh) * 2016-02-06 2017-08-15 北京华昊中天生物技术有限公司 脱环氧埃坡霉素衍生物制剂、制备及其治疗肿瘤的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034437A2 (en) * 1998-12-08 2000-06-15 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
IL157443A0 (en) * 2001-03-14 2004-03-28 Bristol Myers Squibb Co Pharmaceutical compositions for the treatment of cancer including an epothilone analog and a chemotherapeutic agent

Also Published As

Publication number Publication date
TNSN07025A1 (en) 2008-06-02
US20090041715A1 (en) 2009-02-12
IL180604A0 (en) 2008-03-20
AU2005266484A1 (en) 2006-02-02
EP1773334A1 (en) 2007-04-18
KR20070037498A (ko) 2007-04-04
WO2006010585A1 (en) 2006-02-02
JP2008507573A (ja) 2008-03-13
TW200616626A (en) 2006-06-01
RU2007106931A (ru) 2008-09-10
CA2573949A1 (en) 2006-02-02
BRPI0513825A (pt) 2008-05-20
MX2007000971A (es) 2007-04-10
CN1988904A (zh) 2007-06-27
MA28812B1 (fr) 2007-08-01
ZA200700201B (en) 2008-02-27

Similar Documents

Publication Publication Date Title
WO2007089445A3 (en) Ang2 and vegf inhibitor combinations
BR112021025537A2 (pt) Azacitidina em combinação com venetoclax, gilteritinibe, midostaurina ou outros compostos para o tratamento de leucemia ou síndrome mielodisplásica
LTPA2017011I1 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
BRPI0816919A2 (pt) Redução de infecções concomitantes em porcos pelo uso de antígeno pcv2.
NO20091576L (no) Sammensetninger av TRL-ligander og antiviraler
CL2007003686A1 (es) Compuestos derivados de indol con anillo unido en las posiciones 4,5; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para tratar una infeccion viral.
CR20130351A (es) Anticuerpos monoclonales humanos para la quinasa-1 tipo receptor de activina (diviisional 9819)
NI200800176A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de la depresión
NO20090047L (no) Anti-DLL4-antistoffer og fremgangsmater for anvendelse av disse
WO2006107745A3 (en) Composition for treatment of menopause
EA200900767A1 (ru) Антагонистические антитела против ephb3
EA201000903A1 (ru) Антитела к pcrv-антигену pseudomonas aeruginosa
WO2008043052A3 (en) Human antibodies neutralizing human metapneumovirus
WO2005074598A3 (en) Nitroxyl progenitor compounds and methods of use
CL2007002671A1 (es) Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc.
NO20075662L (no) Roflumilast for behandlingen av pulmonal hypertensjon
NO20084320L (no) Antistoffer mot EGFL7 og fremgangsmater for anvendelse av disse
NO20071038L (no) Epotilonkombinasjoner.
HRP20090511T1 (en) Compositions for vaginal use
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
EA201070637A1 (ru) Соединения циклоалкилокси- и гетероциклоалкилоксипиридина как модуляторы гистаминового рецептора н
JP2008542528A5 (no)
EA201000433A1 (ru) Лечение вазомоторных симптомов
WO2007014318A3 (en) Zebrafish models of acute myelogenous leukemia
DK1838716T3 (da) Olanzapinpamota-dihydrat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application